El-Rashidy; Ragab
Patent Applications and Registrations
Patent applications and USPTO patent grants for El-Rashidy; Ragab.The latest application filed is for "treatment of huntington's disease".
- El-Rashidy; Ragab - Deerfield IL
| Patent | Date |
|---|---|
| Treatment of huntington'S disease Grant 9,408,865 - El-Rashidy August 9, 2 | 2016-08-09 |
| Treatment Of Huntington's Disease App 20150071897 - El-Rashidy; Ragab | 2015-03-12 |
| Treatment of Huntington's disease Grant 8,889,125 - El-Rashidy November 18, 2 | 2014-11-18 |
| Treatment of Huntington's Disease App 20140271592 - El-Rashidy; Ragab | 2014-09-18 |
| Method for the treatment of prostate cancer App 20060217316 - El-Rashidy; Ragab | 2006-09-28 |
| Method for ameliorating male erectile dysfunction App 20040092493 - El-Rashidy, Ragab ; et al. | 2004-05-13 |
| Amorphous paroxetine composition Grant 6,638,948 - Ronsen , et al. October 28, 2 | 2003-10-28 |
| Apomorphine-containing dosage form for ameliorating male erectile dysfunction App 20030073715 - El-Rashidy, Ragab ; et al. | 2003-04-17 |
| Amorphous paroxetine composition Grant 6,503,927 - Ronsen , et al. January 7, 2 | 2003-01-07 |
| Regimen and kit for amelioration of premature ejaculation App 20020035131 - El-Rashidy, Ragab ; et al. | 2002-03-21 |
| Apomorphine-containing dosage forms for ameliorating male erectile dysfunction Grant 6,306,437 - El-Rashidy , et al. October 23, 2 | 2001-10-23 |
| Dosage forms containing apomorphine for ameliorating male erectile dysfunction Grant 6,200,983 - El-Rashidy , et al. March 13, 2 | 2001-03-13 |
| Female sexual dysfunction treatment Grant 6,193,992 - El-Rashidy , et al. February 27, 2 | 2001-02-27 |
| Apomorphine-containing dosage forms for ameliorating male erectile dysfunction Grant 6,121,276 - El-Rashidy , et al. September 19, 2 | 2000-09-19 |
| Apomorphine and sildenafil composition Grant 6,087,362 - El-Rashidy July 11, 2 | 2000-07-11 |
| Amelioration of apomorphine adverse effects Grant 5,994,363 - El-Rashidy , et al. November 30, 1 | 1999-11-30 |
| Treatment of female sexual dysfunction Grant 5,945,117 - El-Rashidy , et al. August 31, 1 | 1999-08-31 |
| Transdermal administration of apomorphine Grant 5,939,094 - Durif , et al. August 17, 1 | 1999-08-17 |
| Controlled release of drugs delivered by sublingual or buccal administration Grant 5,888,534 - El-Rashidy , et al. March 30, 1 | 1999-03-30 |
| Dosage forms and method for ameliorating male erectile dysfunction Grant 5,770,606 - El-Rashidy , et al. June 23, 1 | 1998-06-23 |
| Controlled release of drugs delivered by sublingual or buccal administration Grant 5,624,677 - El-Rashidy , et al. April 29, 1 | 1997-04-29 |
| Transdermal administration of apomorphine Grant 5,562,917 - Durif , et al. October 8, 1 | 1996-10-08 |
| Topical compositions and methods for treatment of male impotence Grant 5,256,652 - El-Rashidy October 26, 1 | 1993-10-26 |
| Dialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using same Grant 4,889,634 - El-Rashidy December 26, 1 | 1989-12-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 